BROADWOOD PARTNERS, L.P.
New York, NY · CIK 1278386 · 13F filing filed 2026-08-14
For Q2 2026 this manager filed a 13F notice: its holdings were reported by another manager.
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| INSIGHT MOLECULAR DIA INC IMDX · 13D · filed 2026-04-27 | 39.7%≈ $75.7m |
| STAAR SURGICAL CO STAA · 13D · filed 2026-03-13 | 32.6%≈ $463.3m |
| LINEAGE CELL THERAPEUTICS IN LCTX · 13D · filed 2025-11-14 | 23.1%≈ $75.8m |
Trades reported as a company insider since 1 Apr 2026
Owning 10% or more of a company, or having someone on its board, makes this manager an insider there: it reports its trades in that company's shares on Form 4 within two business days. Open-market and private purchases and sales only.
| Date | Company | Trade | Value |
|---|---|---|---|
| 2026-04-27 | INSIGHT MOLECULAR DIA INC 10% owner | Bought | $913.4k250.9k shares |
| 2026-04-24 | INSIGHT MOLECULAR DIA INC 10% owner | Bought | $137.2k38.9k shares |
| 2026-04-23 | INSIGHT MOLECULAR DIA INC 10% owner | Bought | $981.3k280.4k shares |
| 2026-04-20 | INSIGHT MOLECULAR DIA INC 10% owner | Bought | $157.9k40.7k shares |
| 2026-04-17 | INSIGHT MOLECULAR DIA INC 10% owner | Bought | $143.2k40.1k shares |
| 2026-04-16 | INSIGHT MOLECULAR DIA INC 10% owner | Bought | $352.1k102.1k shares |